Alto Neuroscience, Inc. (ANRO)

NYSE: ANRO · IEX Real-Time Price · USD

14.99

-0.38 (-2.47%)

At close: Jul 19, 2024, 4:00 PM

14.98

-0.01 (-0.07%)

After-hours: Jul 20, 2024, 12:57 PM EDT

Alto Neuroscience Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	-	0	0	0.21
Gross Profit	-	0	0	0.21
Selling, General & Admin	-	7.52	5.5	3.9
Research & Development	-	30.29	23.69	8.37
Operating Expenses	-	37.81	29.19	12.27
Operating Income	-	-37.81	-29.19	-12.06
Interest Expense / Income	-	1.37	0	0
Other Expense / Income	-	-2.87	-1.48	-2.87
Pretax Income	-	-36.31	-27.71	-9.19
Net Income	-	-36.31	-27.71	-9.19
Shares Outstanding (Basic)	18	4	3	5
Shares Outstanding (Diluted)	-	4	3	5
Shares Change	410.74%	8.27%	-35.80%	-
EPS (Basic)	-	-9.73	-8.04	-1.71
EPS (Diluted)	-	-9.73	-8.04	-1.71
Free Cash Flow	-	-33.92	-21.13	-9.94
Free Cash Flow Per Share	-	-9.09	-6.13	-1.85
Gross Margin	-	-	-	100.00%
Operating Margin	-	-	-	-5740.95%
Profit Margin	-	-	-	-4374.76%
Free Cash Flow Margin	-	-	-	-4734.29%
EBITDA	-	-34.28	-27.11	-9.04
EBITDA Margin	-	-	-	-4305.71%
Depreciation & Amortization	-	0.65	0.61	0.15
EBIT	-	-34.94	-27.71	-9.19
EBIT Margin	-	-	-	-4374.76%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).